Patterns of epidermal growth factor receptor amplification in malignant gliomas.

Amplification of the gene for epidermal growth factor receptor (EGFR) is a common finding in malignant gliomas. We found that 18 of 29 grade 3 and grade 4 gliomas had EGFR amplification when assayed using fluorescence in situ hybridization. The amplification pattern suggests that the amplicon is contained within double minute chromosomes in most cases. EGFR copy number can differ by 20-fold in amplified cells within a single case. Polysomy 7 occurs frequently in both EGFR-amplified and -unamplified cells. More than one-third of the cases had < or = 10 percent of cells with amplified EGFR, and it is likely that these cases would not have been identified by methods that do not examine DNA on a cell by cell basis.

[1]  G. Mohapatra,et al.  Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization , 1995, Genes, chromosomes & cancer.

[2]  M Kiessling,et al.  Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma , 2007, International journal of cancer.

[3]  V. P. Collins,et al.  Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. , 1994, Oncogene.

[4]  P. Carroll,et al.  Epidermal‐growth‐factor‐receptor expression is associated with rapid tumor proliferation in bladder cancer , 1994, International journal of cancer.

[5]  C. Limas,et al.  Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. , 1993, Journal of clinical pathology.

[6]  G. Wahl,et al.  Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Bilous,et al.  Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer. , 1992, European journal of cancer.

[8]  O. Olopade,et al.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. , 1992, Cancer research.

[9]  E. Newcomb,et al.  p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. , 1992, Cancer research.

[10]  R. Cawthon,et al.  p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. , 1992, Cancer research.

[11]  J. Moossy,et al.  Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis , 1992, Journal of neuropathology and experimental neurology.

[12]  A. Benabid,et al.  EGF receptor amplification and expression in human brain tumours. , 1992, European journal of cancer.

[13]  M. Prados,et al.  Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. , 1992, International journal of radiation oncology, biology, physics.

[14]  G. Unsgaard,et al.  Amplification of the epidermal growth factor receptor gene in human gliomas. , 1991, Anticancer research.

[15]  F Pozza,et al.  Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. , 1991, Anticancer research.

[16]  C. James,et al.  Molecular genetics of human cancer predisposition and progression. , 1991, Mutation research.

[17]  R. White,et al.  Allelotype of human malignant astrocytoma. , 1990, Cancer research.

[18]  D. Bigner,et al.  Cytogenetics of human brain tumors. , 1990, Cancer genetics and cytogenetics.

[19]  G. Gasparini,et al.  Immunocytochemical determination of epidermal growth factor receptor with monoclonal EGFR1 antibody in primary breast cancer patients. , 1990, Oncology.

[20]  M. Waters,et al.  An immunohistochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. , 1990, British Journal of Cancer.

[21]  T Nakamura,et al.  Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer , 1990, Cancer.

[22]  G. Gasparini,et al.  Characterization of node-negative breast cancer by clinico-pathologic and biologic factors. , 1990, Anticancer research.

[23]  B. Dipasquale,et al.  Heterogeneity and modulation of tumor-associated antigens in human glioblastoma cell lines. , 1989, Journal of neurosurgery.

[24]  J. Rey,et al.  Cytogenetic follow-up from direct preparation to advanced in vitro passages of a human malignant glioma. , 1989, Cancer genetics and cytogenetics.

[25]  P. Betta,et al.  Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness. , 1989, Pathologica.

[26]  C. James,et al.  Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.

[27]  P. Humphrey,et al.  Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. , 1988, Cancer research.

[28]  A. Reiner,et al.  Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth fractions, estrogen receptor status and morphological criteria. An immunohistochemical study. , 1988, Pathology, research and practice.

[29]  K. Kinzler,et al.  Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Trent,et al.  Identification of an amplified, highly expressed gene in a human glioma. , 1987, Science.

[31]  R. Camplejohn,et al.  DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors , 1986, The Journal of pathology.